- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Potentially Undervalued Companies
Indian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
74
0 new
Companies with a Value score of at least 3, ordered by Value score
74 companies
Caplin Point Laboratories
Market Cap: ₹153.6b
Engages in the development, production, marketing, and export of generic formulations and branded products in India.
524742
₹2,021.10
7D
-0.8%
1Y
2.7%
Lupin
Market Cap: ₹900.7b
Operates as a pharmaceutical company in India, the United States, and internationally.
LUPIN
₹1,973.60
7D
2.8%
1Y
-10.2%